Intensive blood pressure (BP) control results in significantly better cardiovascular outcomes and lower all-cause mortality in those at increased risk compared with routine BP control, the Systolic Blood Pressure Intervention Trial (SPRINT) has found. However, serious adverse events such as hypotension, electrolyte abnormalities, acute kidney injury or failure, and syncope were also significantly more frequent in the intensive treatment group.